Log In
Print this Print this

OpsiSporin (MTD202)

  Manage Alerts
Collapse Summary General Information
Company Midatech Pharma plc
DescriptionThree month sustained release formulation of cyclosporine A
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPreclinical
Standard IndicationUveitis
Indication DetailsTreat non-infective uveitis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today